Use of intravenous immunoglobulin and adjunctive therapies in the treatment of primary immunodeficiencies
نویسندگان
چکیده
a Robert Wood Johnson Clinical Scholars Program, University of Pennsylvania, Philadelphia, PA, USA b Division of Pulmonary, Allergy and Critical Care, University of Pennsylvania School of Medicine, Leonard Davis Institute of Economics, University of Pennsylvania, Philadelphia, PA, USA c Immune Deficiency Foundation, Towson, MD, USA d The Department of Pediatrics, State University of New York at Buffalo, School of Medicine and Biomedical Sciences, Women's and Children's Hospital of Buffalo, Buffalo, NY, USA e Division of Allergy and Immunology, Rainbow, Babies and Children's Hospital, Case Western Reserve University, USA f Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA g Division of Immunology, Children's Hospital Boston, Boston, MA, USA h Department of Pediatrics, Harvard Medical School, Boston, MA, USA i Division of Allergy and Immunology, Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA j Department of Medicine and Clinical Immunology, Mount Sinai School of Medicine, New York, USA k Division of Allergy & Immunology, Children's Memorial Hospital, Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA l Division of Allergy and Immunology, Department of Pediatrics, University of Toledo College of Medicine, Toledo, OH, USA m Dallas Allergy Immunology, Dallas TX, USA n Department of Geography, University of Wisconsin-Milwaukee, Milwaukee, WI, USA o Division of Immunology, Children's Hospital of Philadelphia, Department of Pediatrics, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
منابع مشابه
Cost-effectiveness analysis of subcutaneous immunoglobulin replacement therapy in Iranian patients with primary immunodeficiencies
Background: Economic evaluation of subcutaneous immunoglobulin therapy (SCIG) is important, and it has recently been used for treatment of patients with primary immunodeficiency (PID) diseases, and can improve allocation of resources in health care systems. The present research aimed at providing an economic assessment of SCIG and IVIG (intravenous immunoglobulin therapy) adm...
متن کاملTreatment of Severe Alopecia Areata Using Methotrexate as an Adjunctive Drug in Combination with Intravenous and Oral Corticosteroid
Background: Alopecia areata is one of the most common human autoimmune disorders and its severe types are refractory to all conventional therapies. Corticosteroids have been used in severe alopecia areata since 1950s but there is concern over complications caused by high doses of corticosteroids. Methotrexate has been used as an adjunctive therapy in some autoimmune disorders and has been propo...
متن کاملUses of intravenous immunoglobulin
Adjuvant high dose IVIgs are being used increasingly in a range of immune-mediated and auto-immune diseases. Although numerous immunomodulatory mechanisms have been suggested, the exact mechanisms of action are poorly understood. The efficacy of IVIg in certain diseases has been proven in clinical trials, in so far as IVIg is approved as the therapy of choice for Kawasaki syndrome and idiopathi...
متن کاملNeutropenia Following Intravenous Immunoglobulin Therapy in Pediatric Patients with Idiopathic Thrombocytopenic Purpura
Background: Children with idiopathic thrombocytopenic purpura who are treated with intravenous immunoglobulin therapy might experience a decline in their absolute neutrophil count. The aim of this study was to investigate the incidence of neutropenia following intravenous immunoglobulin therapy in children with idiopathic thrombocytopenic purpura undergoing intravenous immunoglobulin therapy. ...
متن کاملUse of Corticosteroid in Children with Unresponsiveness to Intravenous Immunoglobulin in Kawasaki Disease
Background Kawasaki Disease (KD) is a vasculitis with multi-organ involvementof unknown etiology; it is the most common cause of pediatric-heart diseases in developed countries. Treatment with Intravenous Immunoglobulin (IVIG) prevents coronary artery lesions; although there are some IVIG-resistant cases, combination therapy with corticosteroids and IVIG is one of the recommendations for treatm...
متن کاملAssociation between Anti-IgA Antibody and Development of Adverse Reactions in Immunodeficient Patients Under Immunoglobulin Therapy
Background: Mild to severe post-transfusion adverse reactions have been reported in a proportion of immunodeficient patients receiving intravenous immunoglobulin (IVIg). Anti-IgA antibody has been proposed to be associated with development of such reactions. Objective: To assess the association between anti-IgA levels of different isotypes and adverse reactions induced in immunodeficient patien...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2009